FS
Highly rated in
27
conditions
Highly rated in
27
conditions
Check Dr. Felipe Samaniego's experience treating your condition:
About Dr. Felipe Samaniego

Felipe Samaniego is an Oncologist in Houston, Texas. Samaniego has been practicing medicine for over 39 years and is highly rated in 27 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. He is licensed to treat patients in Texas. Samaniego is currently accepting new patients.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 7 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Felipe Samaniego it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Felipe Samaniego accepts the following insurance:

  •  Ambetter
Locations
1515 Holcombe Blvd, Houston, TX 77030
Background & Education
Graduate Institution
Harvard Medical School, 1983
Specialties
Oncology
Licenses
Internal Medicine in TX
Hospital Affiliations
University Of Texas MD Anderson Cancer Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase Ia/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients With CLL/SLL or Non-Hodgkin's Lymphomas
Phase II Study of Zevalin for the Treatment of Early-Stage Indolent Lymphomas
Rituximab (IDEC-C2B8) Plus GM-CSF in Patients With Follicular B-Cell Lymphoma
A Phase II Study of Revlimid in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Hodgkin's Lymphoma (NHL)
View 5 Less Clinical Trials -

126 Total Publications

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors